newsfilter
← Latest News
Business Wire·

AIM ImmunoTech Board Issues Letter to Shareholders

Corrects the Record Regarding Activist Group's False and Misleading Statements Highlights Evidence of Group's Scheme to Have Jorgl Serve as the "Face of the Activist" to Help Them "Get Control" Without Paying a Premium